507
Participants
Start Date
February 24, 2017
Primary Completion Date
April 17, 2019
Study Completion Date
April 30, 2019
Sotagliflozin (SAR439954)
"Pharmaceutical form: tablet~Route of administration: oral"
Placebo
"Pharmaceutical form: tablet~Route of administration: oral"
Metformin
"Pharmaceutical form: tablet~Route of administration: oral"
Sulfonylurea
"Pharmaceutical form: tablet~Route of administration: oral"
Investigational Site Number 3483007, Budapest
Investigational Site Number 3483008, Budapest
Investigational Site Number 3483010, Budapest
Investigational Site Number 3483004, Budapest
Investigational Site Number 3483006, Budapest
Investigational Site Number 1003004, Sofia
Investigational Site Number 4103006, Seoul
Investigational Site Number 8043001, Kyiv
Investigational Site Number 3483009, Hatvan
Investigational Site Number 8043003, Kyiv
Investigational Site Number 8043002, Kyiv
Investigational Site Number 4103010, Seoul
Investigational Site Number 1003003, Plovdiv
Investigational Site Number 3483011, Gyula
Investigational Site Number 3483005, Kecskemét
Investigational Site Number 1003002, Rousse
Investigational Site Number 4103005, Seoul
Investigational Site Number 3483003, Pécs
Investigational Site Number 2333003, Pärnu
Investigational Site Number 3483001, Balatonfüred
Investigational Site Number 3483012, Zalaegerszeg
Investigational Site Number 4103001, Goyang-Si, Gyeonggi-Do
Investigational Site Number 4103011, Guri-Si, Gyeonggi-Do
Investigational Site Number 4103003, Seongnam-Si, Gyeonggi-Do
Investigational Site Number 8403033, Hatboro
Investigational Site Number 8403005, Burke
Investigational Site Number 4103009, Wonju-Si, Gangwon-Do
Investigational Site Number 8403028, Greensboro
Investigational Site Number 8403015, Shelby
Investigational Site Number 8403032, Orlando
Investigational Site Number 8403006, Pembroke Pines
Investigational Site Number 8403020, North Miami Beach
Investigational Site Number 8403013, Port Charlotte
Investigational Site Number 8403029, Bradenton
Investigational Site Number 8403004, New Port Richey
Investigational Site Number 8403008, Palm Harbor
Investigational Site Number 8403026, Ocoee
Investigational Site Number 8403030, Kingsport
Investigational Site Number 8403011, Flint
Investigational Site Number 8403025, Richfield
Investigational Site Number 6163002, Poznan
Investigational Site Number 8403002, Dallas
Investigational Site Number 8403022, Houston
Investigational Site Number 8403001, Northglenn
Investigational Site Number 8403007, Nampa
Investigational Site Number 8403003, Litchfield Park
Investigational Site Number 8403018, Peoria
Investigational Site Number 8403021, Henderson
Investigational Site Number 8403019, Los Angeles
Investigational Site Number 8403012, Huntington Park
Investigational Site Number 8403034, Montclair
Investigational Site Number 8403016, Spring Valley
Investigational Site Number 8403014, Tustin
Investigational Site Number 8403009, Greenbrae
Investigational Site Number 6423002, Iași
Investigational Site Number 6163005, Gdansk
Investigational Site Number 6163006, Gdynia
Investigational Site Number 6163003, Katowice
Investigational Site Number 6163001, Warsaw
Investigational Site Number 6163004, Wroclaw
Investigational Site Number 6423004, Bucharest
Investigational Site Number 7033006, Bratislava
Investigational Site Number 7033001, Bratislava
Investigational Site Number 7033002, Bratislava
Investigational Site Number 7033004, Malacky
Investigational Site Number 7033003, Štúrovo
Investigational Site Number 7033007, Trenčín
Investigational Site Number 4103007, Seoul
Investigational Site Number 8263012, Birmingham
Investigational Site Number 8263009, Cardiff
Investigational Site Number 8263007, Glasgow
Investigational Site Number 8263008, Hexham
Investigational Site Number 8263003, Inverness
Investigational Site Number 8263014, Liverpool
Investigational Site Number 8263011, Manchester
Investigational Site Number 8263010, Reading
Lead Sponsor
Collaborators (1)
Sanofi
INDUSTRY
Lexicon Pharmaceuticals
INDUSTRY